LAMEDITECH Statistics
Total Valuation
LAMEDITECH has a market cap or net worth of KRW 61.57 billion. The enterprise value is 58.30 billion.
Market Cap | 61.57B |
Enterprise Value | 58.30B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
LAMEDITECH has 8.77 million shares outstanding. The number of shares has increased by 30.20% in one year.
Current Share Class | 8.77M |
Shares Outstanding | 8.77M |
Shares Change (YoY) | +30.20% |
Shares Change (QoQ) | +1.22% |
Owned by Insiders (%) | 29.44% |
Owned by Institutions (%) | 0.00% |
Float | 4.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 8.42 |
PB Ratio | 4.34 |
P/TBV Ratio | 4.46 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -5.58 |
EV / Sales | 7.97 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3.85 |
Financial Position
The company has a current ratio of 11.75, with a Debt / Equity ratio of 0.27.
Current Ratio | 11.75 |
Quick Ratio | 7.20 |
Debt / Equity | 0.27 |
Debt / EBITDA | n/a |
Debt / FCF | -0.25 |
Interest Coverage | -164.50 |
Financial Efficiency
Return on equity (ROE) is -53.87% and return on invested capital (ROIC) is -30.39%.
Return on Equity (ROE) | -53.87% |
Return on Assets (ROA) | -27.57% |
Return on Invested Capital (ROIC) | -30.39% |
Return on Capital Employed (ROCE) | -54.18% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.30 |
Inventory Turnover | 1.48 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.85% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -51.85% |
50-Day Moving Average | 7,230.60 |
200-Day Moving Average | 7,975.05 |
Relative Strength Index (RSI) | 46.56 |
Average Volume (20 Days) | 206,886 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LAMEDITECH had revenue of KRW 7.32 billion and -10.44 billion in losses. Loss per share was -1,201.53.
Revenue | 7.32B |
Gross Profit | 2.89B |
Operating Income | -10.67B |
Pretax Income | -10.44B |
Net Income | -10.44B |
EBITDA | -10.13B |
EBIT | -10.67B |
Loss Per Share | -1,201.53 |
Balance Sheet
The company has 7.04 billion in cash and 3.77 billion in debt, giving a net cash position of 3.27 billion or 372.80 per share.
Cash & Cash Equivalents | 7.04B |
Total Debt | 3.77B |
Net Cash | 3.27B |
Net Cash Per Share | 372.80 |
Equity (Book Value) | 14.18B |
Book Value Per Share | 1,616.61 |
Working Capital | 12.59B |
Cash Flow
In the last 12 months, operating cash flow was -11.31 billion and capital expenditures -3.82 billion, giving a free cash flow of -15.13 billion.
Operating Cash Flow | -11.31B |
Capital Expenditures | -3.82B |
Free Cash Flow | -15.13B |
FCF Per Share | -1,725.23 |
Margins
Gross margin is 39.52%, with operating and profit margins of -145.80% and -142.74%.
Gross Margin | 39.52% |
Operating Margin | -145.80% |
Pretax Margin | -142.74% |
Profit Margin | -142.74% |
EBITDA Margin | -138.44% |
EBIT Margin | -145.80% |
FCF Margin | n/a |
Dividends & Yields
LAMEDITECH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -30.20% |
Shareholder Yield | n/a |
Earnings Yield | -16.96% |
FCF Yield | -24.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LAMEDITECH has an Altman Z-Score of 4.45 and a Piotroski F-Score of 1.
Altman Z-Score | 4.45 |
Piotroski F-Score | 1 |